JPM – Talk Bio

Sionna and Odyssey Therapeutics Kick Off 2025 Biotech IPO Wave with SEC Filings

3 months ago talkbio0Tagged 2025, File (record), Health care facility, Industry, IPO, JPM, Market, Odyssey, Sionna

Sionna Therapeutics, Odyssey Therapeutics, IPO filings, biotech industry, JPM Healthcare Conference, 2025 IPO market

GSK Initiates JPM Deal-making with $1 Billion Acquisition of IDRx for Rare Cancer Treatment

3 months ago talkbio0Tagged Acquisition, IDRx, JPM, Malignant Neoplasms, SmithKline Beecham

GSK, IDRx, JPM, rare cancer, acquisition, biotech, pharmaceuticals

Biopharma’s New Horizon: Industry Leaders Converge at JPM 2025

4 months ago talkbio0Tagged Biopharma, Biotechnology, Clustered Regularly Interspaced Short Palindromic Repeats, Doudna, Drug Industry, Gene Modification, Health care facility, healthcare, Janet, Jennifer, JPM, Robert Nelsen, Woodcock

JPM 2025, Biopharma, Jennifer Doudna, Janet Woodcock, Robert Nelsen, Scott Gottlieb, Healthcare, Gene Editing, CRISPR, Pharmaceutical Industry, Biotechnology

Navigating JPM Week 2024: Insights and Opportunities in Biopharma

5 months ago talkbio0Tagged Biopharma, deal-making, Industry, Investments, IPOs, JPM, M&A, Network, regulatory, trends qualifier

JPM Week 2024, Biopharma, Industry Insights, Networking, Deal-making, Investment, M&A, IPOs, Regulatory Trends